|
Report
Number
|
Description
|
Category
|
Date
Issued
|
| 310 |
Rx-360 Summary of Title X of the Food and Drug Administration Safety and Innovation Act Establishes Requirements to Prevent Drug Shortages
|
Legislation |
17-July-12 |
| 309 |
EMA Publishes 32 Questions and Answers on the Falsified Medicines Act
|
Guidance |
12-July-12 |
| 305 |
The FDA has submitted a formal application to start a supply chain security pilot for drug product and API's
|
Guidance |
26-June-12 |
| 304 |
New ANVISA Draft GMP Requirements for Excipients
|
Guidance |
18-June-12 |
| 303 |
Time and Temperature Sensitive Label Label to Become Mandatory on 1 July 2012
|
Guidance |
12-June-12 |
| 302 |
G8 nations met at Camp David on May 18-19, 2012 to collaborate against counterfeit medicines
|
Enforcement |
31-May-12 |
| 296 |
Read the Rx-360 Summary of MHRA's Falsified Medical Products Strategy 2012-2015
|
Counterfeits |
17-May-12 |
| 295 |
Read the Rx-360 Summary of The White House's Executive Order -- Promoting International Regulatory Cooperation
|
Guidance |
16-May-12 |
| 293 |
Rx-360 Summary of the FDA Global Engagement Report
|
Guidance |
08-May-12 |
| 292 |
Rx-360 Summary of Draft EMA Process Validation Guidance
|
Guidance |
23-Apr-12 |
| N/A |
Medicines Control Council of South Africa Publishes Draft Guidance for Distribution of Pharmaceuticals
|
Guidance |
25-Apr-12 |
| 286 |
Read the Rx-360 Summary of US House Draft Bill to Prevent Drug Shortages by Amending the FD&C Act |
Legislation |
09-Apr-12 |
| 285 |
Read the Rx-360 Summary of API Regulatory Inspection Sharing Programme |
Regulation |
09-Apr-12 |